LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
Other Equity
LivaNova PLC
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LivaNova PLC
NASDAQ:LIVN
|
Other Equity
-$45.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Other Equity
$20m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Other Equity
£6.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Other Equity
-£4.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Other Equity
-£540k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Other Equity?
Other Equity
-45.2m
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Other Equity amounts to -45.2m USD.
What is LivaNova PLC's Other Equity growth rate?
Other Equity CAGR 5Y
-10%
Over the last year, the Other Equity growth was -10%.